Novartis’ Q2 net profit declines by 9%

Novartis India Ltd. | Trading | Miscellaneous | BSE: 500672 | NSE: NOVARTIND

25 Oct 2012 Evaluate

Novartis India has reported results for second quarter ended September 30, 2012

The company’s net profit for the quarter has declined by 8.89% at Rs 39.34 crore as compared to Rs 43.18 crore for the corresponding quarter in the previous year. The company’s total income has increased by 8.42% at Rs 237.43 crore for quarter under review as compared to Rs 218.98 crore for the quarter ended September 30, 2011.

Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.

Peers

Company Name	CMP
Redington	399.55
Adani Enterprises	2945.60
Amrapali Industries	37.20
Rashi Peripheral	890.75
ABans Enterprises	27.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.